Half-year report · Q2
8938.TEDINET S100USCS
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥484m | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥12m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | −¥96m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥8m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥192m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥124m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥112m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥0 | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥198m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥99m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥0 | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | −¥99m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥8.4bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥644m | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥593m | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.8bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥304m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥187m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥44m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥335m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥38m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥65m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥49m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥45m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥45m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-0.07 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.91 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.99 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 90.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.0% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥186m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥180m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥66m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥66m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥18m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥199m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥199m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥192m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥418m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥418m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥75m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥66m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥66m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥20m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥484m |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥484m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥95m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥484m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥484m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥95m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 529
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 1262500 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.1394 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 968800 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.1070 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 402600 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0444 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 242900 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0268 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 172400 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0190 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 133700 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0147 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 112000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0123 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 111000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 110000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0121 | |
| Number of shares held | CurrentQuarterInstant | 5556500 | |
| Shareholding ratio | CurrentQuarterInstant | 0.6139 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 9048000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 90480 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 2400 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 9051000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 90480 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 600 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 600 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 600 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 600 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0000 | |
| Cash and deposits | Prior1YearInstant | 2769000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 2179000000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 142000000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant | 148000000 | JPY |
| Operating loans ca | Prior1YearInstant | 1068000000 | JPY |
| Operating loans ca | CurrentQuarterInstant | 1420000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 17000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 13000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 0 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 0 | JPY |
| Short term loans receivable | Prior1YearInstant | 8000000 | JPY |
| Short term loans receivable | CurrentQuarterInstant | 8000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |